Imagine having to find the right key to open a lock among millions of possible combinations. That's the challenge researchers face when predicting how strongly a peptide (a short amino acid chain) binds to a protein. This interaction is crucial for drug discovery, but computational models are often tested too simply.
A new study on arXiv put 10 peptide representation models, ESM-2 protein embeddings, and 6 regressors to the test on 11,349 peptide-protein pairs. The twist? They used three different test types: one with peptides similar to training data, one with known proteins but new peptides, and one with completely unseen proteins.
Results are striking: mean Spearman correlation ranges from 0.46 to 0.67 depending on the test. The best model shifts dramatically: with known proteins, a classic combo (ECFP fingerprints + Random Forest) wins, but for new proteins a transformer-based approach (HELM-BERT + Extra Trees) takes the lead. Also, representation differences matter most with limited training data and fade with more data.
Surprisingly, advanced techniques like PeptideCLM-2 adaptation or element-wise interaction features gave no consistent edge over simpler methods. The lesson? To truly evaluate these models, the test must match the real-world use case: a single score isn't enough.
